documents: FDA-2023-N-0061-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-0061-0002 FDA FDA-2023-N-0061 Reference Summary List for Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under sections 503A and 503B Supporting & Related Material Background Material 2024-03-20T04:00:00Z 2024 3     2024-03-20T15:34:54Z   0 0 0900006486487b7b

Links from other tables